$AFFX (Affymetrix Inc.)

$AFFX {{ '2016-03-28T19:35:01+0000' | timeago}} • Announcement

$TMO said $AFFX's BoD concluded that its merger agreement remains superior and continues to recommend that $AFFX stockholders vote in favor of transaction at March 31 stockholder meeting. $TMO said it is confident that $AFFX stockholders will show their resounding support for fully financed, all cash merger by voting in favor of its deal.

$BA {{ '2017-07-26T18:19:22+0000' | timeago}} • Announcement

Dreamliner maker Boeing raised its earnings outlook for 2017. $BA now expects non-GAAP EPS of $9.80-10.00 vs. previous guidance for $9.20-9.40 and raised its GAAP EPS by $0.75 to between $11.10-11.30, its second upward revision in 2017. Revenue is still expected between $90.5-92.5Bil, including between 760 to 765 commercial deliveries.

$BA {{ '2017-07-26T17:55:57+0000' | timeago}} • Announcement

$BA said it expects to cut its 2017 capex by $300MM, which is not surprising as its biggest investments for 2017 are already out of the way. The company also said it would contribute $3.5Bil of common stock to its pension plan during 3Q, which is expected to provide $700MM in cash tax savings.

$BA {{ '2017-07-26T17:38:10+0000' | timeago}} • Announcement

$BA derives a significant portion of revenues from a handful of commercial airlines. For 2Q, commercial aircraft deliveries fell to 183 vs. 199 a year ago. Boeing still expects to deliver 760-765 jetliners in 2017. Defense segment sales fell 4% to $6.8Bil, but profit climbed 50% and operating margin improved 4% due to cost cutting efforts.

$BA {{ '2017-07-26T16:03:38+0000' | timeago}} • Announcement

Boeing, world's biggest plane maker, reported that its revenues fell 8% to $22.74Bil. However, the company swung to a profit of $1.76Bil vs. $234MM loss in 2Q16 due to the charges (> $2Bil) related to the 787, 747 and KC-46 tanker aircraft programs. $BA reported strong operating cash flow of $5Bil, of which 787 Dreamliner contributed about $530MM.

$TMO {{ '2017-07-26T14:06:23+0000' | timeago}} • Webcast

$TMO said the upward revision of 2017 financial outlook mainly reflected the less adverse foreign exchange environment. The company continues to expect 4% organic revenue growth for the year. Excluding the effect of foreign exchange headwinds, adjusted EPS is seen growing 12-14%. Adjusted operating margin is forecast to grow 50-60 basis points YoY.

$TMO {{ '2017-07-26T13:46:17+0000' | timeago}} • Webcast

Scientific equipment maker $TMO said pharma and biotec continued to be its strongest end markets in 2Q17, with mid-single digits growth. The company's growth strategy remains centered on launching innovative products and leveraging the scale in Asia Pacific and emerging markets. In 2Q17, Thermo Fisher completed $250MM of share buybacks.

$BA {{ '2017-07-26T13:21:53+0000' | timeago}} • Infographic

$BA Boeing Company Earnings AlphaGraphic: Q2 2017 Highlights

$TMO {{ '2017-07-26T12:48:19+0000' | timeago}} • Infographic

$TMO Thermo Fisher Scientific, Inc. Earnings AlphaGraphic: Q2 2017 highlights

$TMO {{ '2017-07-26T10:56:26+0000' | timeago}} • Announcement

Among $TMO’s business segments, Life Sciences Solutions posted a 3% YoY growth in 2Q17 revenues. Analytical Instruments segment revenues surged 47%, reflecting the acquisition of FEI Company last year. Revenues of the Specialty Diagnostics segment and Laboratory Products & Services segment advanced 1% and 4%, respectively, compared to 2Q16.

$TMO {{ '2017-07-26T10:42:34+0000' | timeago}} • Announcement

$TMO revised up its fiscal 2017 revenue guidance to the range of $19.71-$19.89Bil from the previous outlook of $19.51-$19.71Bil, indicating an 8-9% annual growth. The guidance of adjusted EPS has been raised to $9.15-$9.28 per share from the earlier forecast of $9.12-$9.28 per share, which will result in an 11-12% YoY increase.

$TMO {{ '2017-07-26T10:33:50+0000' | timeago}} • Announcement

Medical instruments maker $TMO reported strong results for 2Q17, continuing the recent trend. Earnings of the company, which is currently on an acquisition spree, jumped 20% YoY to $1.56 per share. Adjusted earnings, excluding special items, grew 13% to $2.3 per share. The bottom line growth was driven by a 10% increase in revenues to $4.99Bil.

$TGI {{ '2017-07-25T17:09:42+0000' | timeago}} • Announcement

$TGI signed agreement with $BA to provide various hydraulic and mechanical actuation assemblies for legacy $BA programs, including the Next-Generation 737, 737 MAX, 747-8, 767, 767-2C and 777, and for the 777X, $BA's newest family of twin-aisle airplanes.

$ABT {{ '2017-07-25T15:58:08+0000' | timeago}} • Announcement

$ABT has announced that the first patient has been enrolled in a clinical study evaluating the short-term use of common blood thinning medicines, called dual antiplatelet therapy (DAPT), after receiving a Xience everolimus-eluting coronary stent to unblock coronary arteries. Approx 2,000 patients at 100 sites in the US and Asia will be studied.

$BIIB {{ '2017-07-25T14:47:25+0000' | timeago}} • Announcement

$BIIB, which competes with $ABT and $PFE, posted record 2Q17 revenue, on strong Spinraza demand in the US, though YoY profit fell 18% on higher expenses. Net earnings attributable to Biogen plunged to $862.8MM, while diluted EPS fell 15.03% to $4.07. Revenue, however, jumped 6% to $3.1Bil. $BIIB lifted its outlook due to strong Spinraza sales.

$PKI {{ '2017-07-24T21:21:06+0000' | timeago}} • Announcement

$PKI BoD declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2017. This dividend is payable on Nov. 10, 2017 to all shareholders of record at the close of business on Oct. 20, 2017.

$BA {{ '2017-07-24T17:41:39+0000' | timeago}} • Announcement

$BA today unveiled its 2017 Pilot and Technician Outlook at EAA AirVenture Oshkosh, an annual gathering of aviation professionals. Boeing forecasts a demand for more than 1.2MM pilots and technicians over the next 20 years.

$GE {{ '2017-07-21T18:59:39+0000' | timeago}} • Webcast

John Flannery, who is to be $GE's 13th CEO effective Aug 1, 2017, brushed aside concerns that the company might find itself in a state of limbo during the transition period. He said there is no operational paralysis within the team, adding robust discussions will happen in November regarding the future of course of $GE's operations.

$GE {{ '2017-07-21T18:13:06+0000' | timeago}} • Webcast

$GE reiterated its FY17 net earnings guidance of $1.60-1.70 per share on organic sales growth, which is expected in the range of 3-5%. The company added that EPS is trending to the bottom end of the projected range, as Oil and Gas continues to witness weakness.

$GE {{ '2017-07-21T17:28:46+0000' | timeago}} • Webcast

Cash flow from operations, one of $GE's closely watched financial metric, plummeted 67% to $3.6Bil in 2Q17. The Boston, Massachusetts-based conglomerate said this was primarily due to the sale of its appliances division.

$GE {{ '2017-07-21T12:51:53+0000' | timeago}} • Infographic

$GE General Electric Earnings AlphaGraphics: Q2 2017 highlights

Recent Transcripts

BA (The Boeing Company)
Wednesday, July 26 2017 - 2:30pm
TPH (TRI Pointe Group, Inc.)
Wednesday, July 26 2017 - 2:00pm
IART (Integra LifeSciences Holdings Corporation)
Wednesday, July 26 2017 - 12:30pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, July 26 2017 - 12:30pm
WAT (Waters Corporation)
Tuesday, July 25 2017 - 12:00pm
GE (General Electric Company)
Friday, July 21 2017 - 12:30pm
SNA (Snap-on Incorporated)
Thursday, July 20 2017 - 2:00pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
DHR (Danaher Corp.)
Thursday, July 20 2017 - 12:00pm
HOLX (Hologic Inc.)
Wednesday, May 10 2017 - 8:30pm
CVU (CPI Aerostructures Inc.)
Tuesday, May 9 2017 - 12:30pm
FLDM (Fluidigm Corporation)
Thursday, May 4 2017 - 9:00pm
PKI (PerkinElmer Inc.)
Thursday, May 4 2017 - 9:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
PSDV (pSivida Corp.)
Thursday, May 4 2017 - 8:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
BDX (Becton, Dickinson and Company)
Thursday, May 4 2017 - 12:00pm
BRKR (Bruker Corporation)
Wednesday, May 3 2017 - 8:45pm
QGEN (Qiagen NV)
Wednesday, May 3 2017 - 1:00pm
TECH (Bio-Techne Corp.)
Tuesday, May 2 2017 - 1:00pm

AlphaGraphics you may like